NCT00622323View on ClinicalTrials.gov

Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Type 2 Diabetes Mellitus
Trial Locations (3)

Unknown

Research Site, Paranaque City

Research Site, Pasig

Research Site, Taytay

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

AstraZeneca

INDUSTRY

NCT00622323 - Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients | Biotech Hunter | Biotech Hunter